BioMotiv Creates Sujana Biotech

BioMotiv has formed Sujana Biotech, a new biopharmaceutical company to commercialize technologies for the treatment of inflammatory and vascular disorders. In addition, Sujana Biotech raised $800,000 of a potential $5 million round.